Emergent BioSolutions Inc.EBSNYSE
Loading
Cost of Revenue Over TimeContracting
Percentile Rank50
3Y CAGR-15.3%
5Y CAGR-11.3%
Year-over-Year Change
Direct costs attributable to producing goods sold
3Y CAGR
-15.3%/yr
vs +8.7%/yr prior
5Y CAGR
-11.3%/yr
Recent deceleration
Acceleration
-23.9pp
Decelerating
Percentile
P50
Within normal range
vs 5Y Ago
0.5x
Contraction
Streak
2 yr
Consecutive declineContracting
| Period | Value | YoY Change |
|---|---|---|
| TTM | $392.30M | -41.3% |
| 2024 | $668.20M | -3.1% |
| 2023 | $689.30M | +7.0% |
| 2022 | $644.50M | -34.3% |
| 2021 | $980.40M | +37.3% |
| 2020 | $714.20M | +14.7% |
| 2019 | $622.90M | +34.8% |
| 2018 | $462.00M | +66.6% |
| 2017 | $277.30M | +13.6% |
| 2016 | $244.00M | - |